Mesothelioma Awareness Day is fast approaching By James L. Ferraro | Mesothelioma | Last Modified on Feb 27, 2026 Read More
Janssen Pharmaceuticals hid Elmiron drug injuries information By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Zantac recall leads to federal investigation into... By James L. Ferraro | Zantac Recall | Last Modified on Feb 20, 2026 Read More
Drug injuries: Is a pharmaceutical company liable... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Apr 07, 2026 Read More
Are mesothelioma risks hiding in your home? By James L. Ferraro | Mesothelioma | Last Modified on Feb 27, 2026 Read More
Mislabeled medications could cause drug injuries By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
The serious implications of long-term asbestos exposure By James L. Ferraro | Asbestos Exposure & Claims | Last Modified on Feb 23, 2026 Read More
Purdue Pharma could pay $13 billion in... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 27, 2026 Read More
Elmiron use linked to loss of vision:... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Mesothelioma: Researchers announce hopeful discovery By James L. Ferraro | Mesothelioma | Last Modified on Feb 20, 2026 Read More
Can Zantac transfer from a pregnant woman... By James L. Ferraro | Zantac Recall | Last Modified on Feb 20, 2026 Read More
Zantac recall: FDA says do not take... By James L. Ferraro | Zantac Recall | Last Modified on Feb 20, 2026 Read More